CWH Capital Management’s Gilead Sciences GILD Stock Holding History

CWH Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,395	Closed	-$2.87M	–	49
2015 Q4	$2.87M	Sell	28,395 -85	-0.3%	-$8.85K	1.85%	20
2015 Q3	$2.8M	Sell	28,480 -170	-0.6%	-$18.9K	1.88%	21
2015 Q2	$3.35M	Sell	28,650 -65	-0.2%	-$7.1K	1.97%	19
2015 Q1	$2.82M	Buy	28,715 +800	+3%	+$81.2K	1.72%	22
2014 Q4	$2.63M	Sell	27,915 -330	-1%	-$34.1K	1.72%	25
2014 Q3	$3.01M	Buy	28,245 +475	+2%	+$46.5K	2.34%	19
2014 Q2	$2.3M	Sell	27,770 -220	-0.8%	-$17.1K	1.91%	21
2014 Q1	$1.98M	Sell	27,990 -100	-0.4%	-$7.84K	1.63%	23
2013 Q4	$2.11M	Buy	+28,090	New	+$1.96M	1.81%	22

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CWH Capital Management's GILD Position: Q1 2016 in Review

CWH Capital Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 28,395 shares — an estimated $2.87M sold.

CWH Capital Management first reported a position in GILD in Q4 2013 and held it in 9 quarters. The position peaked at $3.35M in Q2 2015. 1,632 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

CWH Capital Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
CWH Capital Management sold 28,395 Gilead Sciences shares in Q1 2016, an estimated $2.87M.
CWH Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 9 quarters.
CWH Capital Management's Gilead Sciences position peaked at $3.35M in Q2 2015.
1,632 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on CWH Capital Management's 13F filing for Q1 2016, filed 6 May 2016.